Babban Masanin Kimiyya
Wenqiang Yu, Ph.D.
●Babban Masanin Kimiyya na Shirin "973" na kasa;
●Farfesan da aka nada na musamman don Shirin Malaman Chang Jiang;
●PI, Cibiyar Epigenetics, Cibiyar Kimiyyar Halittu ta Jami'ar Fudan;
●Wanda aka nada na musamman mai bincike kuma mai kula da Doctoral na Jami'ar Fudan;
●Shugaban kwamitin kwararru na Methylation Marker na kwamitin Tumor Marker na kungiyar yaki da cutar kansa ta kasar Sin.
A shekarar 1989, ya sauke karatu a Jami’ar Kiwon Lafiya ta Soja ta Hudu, ya kuma sami digiri na farko a fannin likitanci;
A shekarar 2001, ya sami digirin digirgir a Jami’ar Kiwon Lafiya ta Soja ta Hudu;
Daga 2001-2004, ya sami Postdoctoral a Sashen Ci gaba da Genetics, Jami'ar Uppsala, Sweden;
Daga 2004-2007, ya sami Postdoctoral a Makarantar Magungunan Jami'ar Hopkins, Amurka;
A halin yanzu, Farfesa Yu shine PI kuma abokin bincike na Cibiyoyin Kimiyyar Halittu na Jami'ar Fudan, kuma Mataimakin Babban Daraktan Cibiyar Nazarin Genomics da Epigenomics na Jami'ar Fudan.An buga nasarorin bincikensa a manyan mujallu na ilimi na duniya kamar,Yanayi, Halitta HalittakumaJAMA.
lished a cikin manyan mujallu na ilimi na duniya kamar Nature, Nature Genetics da JAMA, tare da mafi girman tasirin sakamako na 38.1.
Shugaba
Lin Hua
Bachelor of Economics na Shanghai JiaoJami'ar Tong.Ta yi aiki a matsayin Babban Manajan Sashen Kamfanin Lissafi na Guosen Securities, abokin tarayya na XIANGDU CAPITAL, abokin tarayya na CHOBE CAPITAL.A matsayinta na shugabar ƙungiyar, ta haɓaka don saka hannun jarin kamfanoni da yawa masu nasara.
ObiO (688238): CGT CDMO masana'anta tare da mafi girma iya aiki;
Novoprotein (688137): mai samar da albarkatun kasa yana mai da hankali kan furotin mai sake haɗuwa;
Leadsynbio: babban kamfani a cikin ilimin halitta;
SinoBay: Kamfanonin kula da ƙwayar cuta da aka yi niyya
Quectel(603236): babbar cibiyar sadarwar sadarwa mara waya ta duniya
XinpelTek: mai da hankali kan kasuwancin guntu na PA RF mara waya;
DGene: mayar da hankali kan kasuwancin dijital na 3D
Bidiyo++: kasuwancin unicorn a yankin AI
Tare da sama da shekaru goma a cikin kasuwar babban birnin kasar, Ms Hua ta sami babban gogewa a harkokin gudanarwa da saka hannun jari.
Daraktan R&D
Wei Li, Ph.D.
Doctor Li ya yi aiki a matsayin Mataimakin mai bincike a Cibiyar Kimiyyar Halittu ta Jami'ar Fudan na tsawon shekaru goma.Ta jagoranci ayyukan bincike guda 3 da suka hada da gidauniyar kimiyyar dabi'a ta kasar Sin,Aikin bincike mai zaman kansa na gabatar da basirakuma da dai sauransu.Ta kuma halarci ayyuka da dama na kasa, ciki har da National 973 Project, Key Project of National Natural Science Foundation da dai sauransu.Ta buga takardun SCI guda 16 a matsayin marubucin farko ko marubucin da ya dace a cikiBinciken Genome, eBiomedicine, Nuclear Acid Bincike da sauransu.(Tarin Tasirin Factor 158.97).
Babban sha'awar bincike:
1. Haɓakawa na Epigenetic algorithms da Multi-omics nazarin ƙwayar cuta.Ƙididdigar tushe guda ɗaya da aka kafa dandali mai faɗin DNA methylation na DNA (WGPS algorithm) a farkon matakin.Sannan an samu taswirar methylation na DNA mai faɗi na farko na ƙwayoyin hanta na ɗan adam.A halin da ake ciki, ta ba da wani sabon tsarin yin shiru na hana ƙwayar cuta a cikin ra'ayi na epigenetics.
2. Allon alamomin halitta gama gari na mugun hali a cikin nau'ikan ciwon daji da yawa ta bayanan omics da yawa.Dangane da hanyoyin WGPS, mun bincika alamomin hypermethylation na musamman tsakanin ciwace-ciwacen daji da na al'ada.
3. Bincike a kan pathogenesis na kunna aikin rubutun kwayoyin halitta ta NamiRNA: Wani nau'in miRNA na nukiliya, wanda muka sanya wa suna NamiRNA (Nuclear Activating miRNA).
Injiniya R&D Likita
Meigui Wang, Ph.D.
Doctor Wang ta sami Ph.D.Digiri daga Jami'ar Kiwon Lafiya ta Kudu a 2019. Ta kuma ci gaba da bin diddigin horar da mazauninta a Asibitin Affiliated na Uku na Jami'ar Sun Yat-sen (2019-2021).Sha'awarta na asibiti shine don ganowa da kuma maganin kansar kansa da wuyansa kamar kansar laryngeal da ciwon daji na nasopharyngeal.Sha'awar bincikenta na mayar da hankali kan ganewar farko na ciwon daji na nasopharyngeal.
Injiniya R&D Likita
Yaping Dong, Ph.D.
Doctor Dong ya sami Ph.D.digiri a cikin magunguna na asibiti daga Jami'ar Kiwon Lafiya ta Fujian a cikin 2020, kuma ta gudanar da bincike bayan-doctoral a Jami'ar Fudan Shanghai Cibiyar Ciwon daji daga 2020 zuwa 2022. A matsayinta na babbar mahalarta, ta halarci ayyuka da yawa na ƙasa, gami da Ma'aikatar Kimiyya da Fasaha Maɓalli Shirin " Gagarumin Ci gaban Sabbin Magungunan Magunguna”, Gidauniyar Kimiyyar Halitta ta kasar Sin da dai sauransu.Ta buga takardu masu inganci da yawa a cikin Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica da Radiation Oncology.